Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Strategic Asset Allocation Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Strategic Asset Allocation Index of 45.2% as of June 2023. Strategic assets (PP&E of $1.07 Billion plus long-term investments of $-) total $1.07 Billion, measured against net assets of $2.36 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 900904 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Strategic Asset Allocation Index (2015–2021)
This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of June 2023, the index stands at 45.2%, representing strategic assets of $1.07 Billion against net assets of $2.36 Billion USD. For live market cap and overall valuation, see 900904 stock market capitalisation.
Annual Strategic Asset Allocation Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Shanghai Shenqi Pharmaceutical Investmen (900904) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 48.8% | $1.17 Billion | $1.17 Billion | $- | $2.39 Billion | ▲ +7.5 pp |
| 2020 | 41.2% | $960.14 Million | $960.14 Million | $- | $2.33 Billion | ▲ +10.2 pp |
| 2019 | 31.0% | $825.07 Million | $825.07 Million | $- | $2.66 Billion | ▲ +0.9 pp |
| 2018 | 30.1% | $783.25 Million | $687.52 Million | $95.73 Million | $2.60 Billion | ▲ +3.7 pp |
| 2017 | 26.5% | $669.73 Million | $556.42 Million | $113.32 Million | $2.53 Billion | ▲ +2.5 pp |
| 2016 | 24.0% | $584.13 Million | $464.65 Million | $119.48 Million | $2.43 Billion | ▼ -0.1 pp |
| 2015 | 24.1% | $550.83 Million | $429.72 Million | $121.11 Million | $2.29 Billion | — |